![Ryan Asay](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Ryan Asay worked as a Director of Investor Relations at Bristol Myers Squibb Co. He then worked as the Head of Investor Relations at Spark Therapeutics, Inc. from 2017 to 2020.
From 2020 to 2024, he worked as the Vice President and Head of Corporate Affairs at Mirati Therapeutics, Inc.
Ehemalige bekannte Positionen von Ryan Asay
| Unternehmen | Position | Ende |
|---|---|---|
| MIRATI THERAPEUTICS | Corporate Officer/Principal | 23.01.2024 |
| SPARK THERAPEUTICS, INC. | Investor Relations Kontakt | 01.02.2020 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
21
Beziehungen ersten Grades
2
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops cancer therapies | Health Technology |
Spark Therapeutics, Inc.
 Spark Therapeutics, Inc. BiotechnologyHealth Technology Develops therapy products for debilitating diseases | Health Technology |
Wählen Sie MarketScreener 
